SCHEMBL13536643

SCHEMBL13536643

Cc1ccc(P(C)(C)=O)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ HPGD P15428 1/20 0.39
▸ ADRA2A P08913 2/20 0.35
▸ ADRA2B P18089 2/20 0.35
▸ ADRA2C P18825 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TSHR P16473 2/20 0.33
▸ HPGDS O60760 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ PRKAB2 O43741 1/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ PRKAA2 P54646 1/20 0.33
▸ PRKAA1 Q13131 1/20 0.33
▸ PRKAG3 Q9UGI9 1/20 0.33
▸ PRKAG2 Q9UGJ0 1/20 0.33
▸ PRKAB1 Q9Y478 1/20 0.33
▸ KCNQ3 O43525 1/20 0.33
▸ KCNQ2 O43526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459606 0.80 HDAC1 (0.46) HDAC1HDAC6HPGDADRA2AADRA2B
SCHEMBL15075596 0.79 HDAC1 (0.38) HDAC1HDAC6HPGDADRA2AADRA2B
SCHEMBL30096957 0.76 FDFT1 (0.41) HPGD
SCHEMBL29849881 0.76 CYP2A6 (0.34) HPGDKCNQ3KCNQ2CYP2E1CYP2A6
SCHEMBL27037217 0.76 NAPRT (0.41) KCNQ3KCNQ2NPC1RAB9ASMN1; SMN2
SCHEMBL23832408 0.76 FDFT1 (0.41) HPGD
SCHEMBL24782533 0.75 HDAC1 (0.38) HDAC1HDAC6ADRA2AADRA2BADRA2C
SCHEMBL15075626 0.74 HDAC1 (0.41) HDAC1HDAC6ADRA2AADRA2BADRA2C
SCHEMBL24899879 0.73 HPGD (0.33) HPGD
SCHEMBL15219348 0.73 KCNQ3 (0.60) HDAC1HDAC6KDM4ELMNAKCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261524-A1 HETEROARYL COMPOUNDS AS INHIBITORS OF TYK2, COMPOSITION AND APPLICATION THEREOF ACCRO BIOSCIENCE (HK) LIMITED (CN) 2022-12-15 — — WO disclosed
US-7649015-B2 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. (US) 2010-01-19 — — US disclosed
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds GILEAD SCIENCES, INC. 2007-01-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds PPA1, PNP, PPME1 HDAC1 1002/4885HDAC6 1504/4885HPGD 1843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback